Following development by the Medicines Safety Group, we now seek comments on a draft communication for primary care on high dose opioids. It highlights the risk of harm from doses above the equivalent of 120mg/day morphine, and signposts to useful resources to support review of patients.
This consultation will run for two weeks and closes at 5pm on Thursday 14th November 2024. To take part, visit the consultations page.